Kuros Biosciences AG | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
Kuros Biosciences AG

BRIEF

published on 06/25/2024 at 07:05, 4 months 26 days ago

Kuros Biosciences Publishes Superior MAXA Study Outcomes in Spine

Kuros Biosciences MagnetOs Spinal Fusion MAXA Study Autograft
PRESS RELEASE

published on 06/25/2024 at 07:00, 4 months 26 days ago

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences announces the publication of MagnetOs MAXA Level 1 study outcomes in Spine, showing superiority over autograft. Study details effectiveness of MagnetOs in posterolateral fusions

Kuros Biosciences MagnetOs MAXA Level 1 Spine Study Bone Healing Technologies
BRIEF

published on 04/24/2024 at 07:05, 6 months 27 days ago

Kuros Biosciences annonce une forte croissance au premier trimestre 2024

Kuros Biosciences Autorisation FDA 510(k) Étude Clinique Croissance Du Premier Trimestre 2024 Augmentation Des Ventes De MagnetOs
BRIEF

published on 04/24/2024 at 07:05, 6 months 27 days ago

Kuros Biosciences Reports Strong Growth in Q1 2024

FDA 510(k) Clearance Clinical Study Kuros Biosciences Q1 2024 Growth MagnetOs Sales Increase
PRESS RELEASE

published on 04/24/2024 at 07:00, 6 months 27 days ago

Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Kuros Biosciences reports strong Q1 2024 performance with 155% increase in direct MagnetOs sales. FDA clearance for MagnetOs Putty and positive EBITDA. Joe Ross appointed SVP Marketing

FDA Clearance Kuros Biosciences MagnetOs Sales Q1 2024 Performance Joe Ross
BRIEF

published on 04/17/2024 at 14:10, 7 months 3 days ago

L'assemblée générale annuelle de Kuros Biosciences AG se termine avec succès

Gouvernance D'Entreprise Assemblée Générale Annuelle Décisions Des Actionnaires Kuros Biosciences AG Approbation Financière
BRIEF

published on 04/17/2024 at 14:10, 7 months 3 days ago

Kuros Biosciences AG's Annual General Meeting Concludes Successfully

Annual General Meeting Corporate Governance Shareholder Decisions Kuros Biosciences AG Financial Approval
PRESS RELEASE

published on 04/17/2024 at 14:05, 7 months 3 days ago

Annual General Meeting of Kuros Biosciences approves all resolutions
Kuros Biosciences AG held its Annual General Meeting, approving all resolutions including financial statements and board member elections

Annual General Meeting Financial Statements Kuros Biosciences Resolutions Board Elections
BRIEF

published on 03/13/2024 at 07:05, 8 months 8 days ago

Kuros Biosciences annonce une croissance remarquable de ses ventes en 2023

Kuros Biosciences Résultats Financiers 2023 Équipement Médical Autorisation De La FDA Croissance Des Ventes De MagnetOs
BRIEF

published on 03/13/2024 at 07:05, 8 months 8 days ago

Kuros Biosciences Reports Remarkable Sales Growth in 2023

Medical Devices FDA Clearance Kuros Biosciences Financial Results 2023 MagnetOs Sales Growth

Accesswire

Published on 11/21/2024 at 12:00, 50 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 50 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 20 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 47 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 50 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 15 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 35 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 44 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 50 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 20 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 52 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 43 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 30 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE